A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

计划入组 106 人 · 首次发布于 2023 年 9 月 21 日

5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

计划入组 92 人 · 首次发布于 2012 年 7 月 30 日

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan

计划入组 177 人 · 首次发布于 2024 年 3 月 7 日

Myelodysplastic syndrome(Calibr-Skaggs)

DISC a

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

FDA Grants Fast Track Designation to Rigel's R289 for Lower-Risk Myelodysplastic Syndrome

ESA Treatment Shows Survival Benefit in Lower-Risk Myelodysplastic Syndromes

Canakinumab Shows Promise in Treating Relapsed/Refractory Lower-Risk Myelodysplastic Syndromes